Dr. Lal Path Labs Ltd. — Board Meeting, 31-10-2025: Outcome of Board Meeting
31-10-2025 | 02:03 pm
31-10-2025 | 02:03 pm
LALPATHLABS board approved Q2/H1 financial results, declared ₹7/share interim dividend, and a 1:1 bonus share issue. They also increased authorized capital from ₹107.96 Cr to ₹200 Cr and introduced RSU Plan 2025 with 5.27 lakh stock options.
No comments yet. Be the first to comment!
